Amyloid-β-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Understanding the pathogenicity of amyloid-beta (Abeta) peptides constitutes a major goal in research on Alzheimer's disease (AD). One hypothesis entails that Abeta peptides induce uncontrolled, neurotoxic ion flux through cellular membranes. The exact biophysical mechanism of this ion flux is, however, a subject of an ongoing controversy which has attenuated progress toward understanding the importance of Abeta-induced ion flux in AD. The work presented here addresses two prevalent controversies regarding the nature of transmembrane ion flux induced by Alphabeta peptides. First, the results clarify that Alphabeta can induce stepwise ion flux across planar lipid bilayers as opposed to a gradual increase in transmembrane current; they show that the previously reported gradual thinning of membranes with concomitant increase in transmembrane current arises from residues of the solvent hexafluoroisopropanol, which is commonly used for the preparation of amyloid samples. Second, the results provide additional evidence suggesting that Abeta peptides can induce ion channel-like ion flux in cellular membranes that is independent from the postulated ability of Alphabeta to modulate intrinsic cellular ion channels or transporter proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · cited 1×
“by thinning the membrane) (Kayed et al. 2004; Sokolov et al. 2004, 2006), (3) Ab modulates, directly or indirectly, the activity of existing ion channel proteins or receptors ( Yankner et al. 1990a, b; Joslin et al. 1991; Mark et al. 1995; Querfurth et al. 1997; Ueda et al. 1997; Ye et al. 1997; Morimoto et al. 1998;…”
BackgroundPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 1×
“One of the current hypotheses for the pathology of Alzheimer’s disease (AD) proposes that amyloid-beta (Ab) peptides induce aberrant, neurotoxic ion flux across cellular membranes (Koh et al. 1990; Arispe et al. 1993a, b; Kawahara et al. 2000; Kourie et al. 2001; Michikawa et al. 2001; Arispe and Doh 2002; Kurganov et…”
BackgroundNeuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938 · cited 1×
“... of Alzheimer’s disease (AD) proposes that amyloid-beta (Ab) peptides induce aberrant, neurotoxic ion flux across cellular membranes (Koh et al. 1990; Arispe et al. 1993a, b; Kawahara et al. 2000; Kourie et al. 2001; Michikawa et al. 2001; Arispe and Doh 2002; Kurganov et al. 2004; Barghorn et al. 2005; Quist et al…”
BackgroundDevi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792 · cited 1×
“One of the current hypotheses for the pathology of Alzheimer’s disease (AD) proposes that amyloid-beta (Ab) peptides induce aberrant, neurotoxic ion flux across cellular membranes (Koh et al. 1990; Arispe et al. 1993a, b; Kawahara et al. 2000; Kourie et al. 2001; Michikawa et al. 2001; Arispe and Doh 2002; Kurganov et…”
BackgroundBarghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice
Lopez, J. R., Lyckman, A., Oddo, S., LaFerla, F. M., Querfurth, H. W., & Shtifman, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05135.x · Cited by 162
Fresh Evidence Points to an Old Suspect: Calcium
Marx, J. (2007) · Science · doi:10.1126/science.318.5849.384 · Cited by 71 · cited 1×
“…included (final concentration in the extracellular solution): 20 mM tetraethylammonium (TEA) ions to block potassium channels (Forsythe et al. 1992; Mathie et al. 1998; Tosetti et al. 1998; Guyon et al. 2005), 1 lM tetrodotoxin to block sodium channels (Forsythe et al. 1992; Toselli et al. 1996;…”
Cited by
Controlling protein translocation through nanopores with bio-inspired fluid walls
Yusko, E. C., Johnson, J. M., Majd, S., Prangkio, P., Rollings, R. C., Li, J., Yang, J., & Mayer, M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.12 · Cited by 660
Self-citationAmyloidogenic Protein–Membrane Interactions: Mechanistic Insight from Model Systems
Butterfield, S. M., & Lashuel, H. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906670 · Cited by 592
Calcium Signaling and Amyloid Toxicity in Alzheimer Disease
Demuro, A., Parker, I., & Stutzmann, G. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.080895 · Cited by 407
Two-Step Mechanism of Membrane Disruption by Aβ through Membrane Fragmentation and Pore Formation
Sciacca, M. F. M., Kotler, S. A., Brender, J. R., Chen, J., Lee, D.-K., & Ramamoorthy, A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.045 · Cited by 362
Brender, J. R., Salamekh, S., & Ramamoorthy, A. (2012) · Accounts of Chemical Research · doi:10.1021/ar200189b · Cited by 357
Williams, T. L., & Serpell, L. C. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08228.x · Cited by 335
Applications of biological pores in nanomedicine, sensing, and nanoelectronics
Majd, S., Yusko, E. C., Billeh, Y. N., Macrae, M. X., Yang, J., & Mayer, M. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.05.002 · Cited by 327
Self-citationAntimicrobial Properties of Amyloid Peptides
Kagan, B. L., Jang, H., Capone, R., Teran Arce, F., Ramachandran, S., Lal, R., & Nussinov, R. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200419b · Cited by 227
Self-citationBurke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127
“…model lipid membranes and neuronal membranes independent from the ability of Aβ to modulate intrinsic cellular ion channels or transporter proteins (Capone et al., 2009) Even intracellular forms of Aβ can alter the electrophysiological properties of cultured human primary neurons (Hou et al.,…”
BackgroundNageeb El-Helaly, S., Abd Elbary, A., Kassem, M. A., & El-Nabarawi, M. A. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1309476 · Cited by 69
“Patients with AD have an abundance of two abnormal structures in their brain; the amyloid plaques and the neurofibrillary tangles that are made of misfolded proteins (Francis et al., 1999; Capone et al., 2009; Rodgers, 2011).”
BackgroundSolvent Retention in Electrospun Fibers Affects Scaffold Mechanical Properties
D’Amato, A. R., Bramson, M. T. K., Corr, D. T., Puhl, D. L., Gilbert, R. J., & Johnson, J. (2018) · Electrospinning · doi:10.1515/esp-2018-0002 · Cited by 43
“HFIP is toxic to cells in the low millimolar range [26].”
BackgroundNeuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
Dworzak, J., Renvoisé, B., Habchi, J., Yates, E. V., Combadière, C., Knowles, T. P., Dobson, C. M., Blackstone, C., Paulsen, O., & Murphy, P. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127730 · Cited by 30
“It should be noted that neurons treated with HFIP Aβ demonstrated slightly decreased baseline frequency and amplitude, with more pronounced effects in Cx3cr1 neurons, corroborating previous reports that residual solvent may be toxic [55].”
ResultBeta-amyloid oligomers: recent developments
Borutaite, V., Morkuniene, R., & Valincius, G. (2011) · bmc · doi:10.1515/bmc.2011.019 · Cited by 9
“It was demonstrated (83) that HFIPderived Ab oligomer preparations contain residual HFIP, which may be responsible for membrane damage, and, consequently, for cytotoxicity observed in studies in vitro.”
BackgroundTang, Y., Zhang, D., Robinson, S., & Zheng, J. (2023) · Advanced Biology · doi:10.1002/adbi.202300070 · Cited by 9
Metadata
- Authors
- Capone, R., Quiroz, F. G., Prangkio, P., Saluja, I., Sauer, A. M., Bautista, M. R., Turner, R. S., Yang, J., & Mayer, M.
- Venue
- Neurotoxicity Research
- Published
- 2009-03-19
- Volume
- 16
- Issue
- 1
- Pages
- 1-13
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2105949921
- Cited by
- 113
- References
- 8
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.